Benchling logo

Benchling Funding & Investors

Benchling makes life science research faster and more collaborative. Biotechnology has the potential to solve humanity’s most pressing challenges, such as disease, renewable energy, clean water, and hunger. The brightest minds are working on these problems but they are equipped with archaic tools. We aspire to fix this and increase the rate of scientific output with a web-based platform that allows researchers to design and run experiments, analyze data, and share results. Hundreds of thousands of scientists all around the world use Benchling to do research. Whether they are at the world’s largest companies, the top research universities, or working on a startup in a garage, scientists use Benchling for the same reason: to be empowered, not encumbered, by their tools. Read about the problems our engineers are solving: benchling.engineering Learn how our Customer Success Representatives work with cutting-edge biotech companies: blog.benchling.com/two-days-in-the-life-of-a-benchling-customer-success-manager Join our team: benchling.com/careers

benchling.com

Total Amount Raised: $411,900,000

Benchling Funding Rounds

  • Series F

    $100,000,000

    Series F Investors

    Altimeter Capital
    Franklin Resources
    Lone Pine Capital
    Tiger Global Management
  • Series E

    $200,000,000

    Series E Investors

    Spark Capital
    Menlo Ventures
    ICONIQ Growth
    Altimeter Capital
    Alkeon Capital Management
    Benchmark
    Byers Capital
    Lux Capital
    Elad Gil
    Thrive Capital
    Lead Edge Capital
    Sequoia Capital Global Equities
  • Series D

    $50,000,000

    Series D Investors

    Spark Capital
    Menlo Ventures
    ICONIQ Growth
    Alkeon Capital Management
    Benchmark
    Lux Capital
    Thrive Capital
  • Series C

    $34,500,000

    Series C Investors

    Menlo Ventures
    Benchmark
    Thrive Capital
    Y Combinator
    Lead Edge Capital
  • Series B

    $14,500,000

    Series B Investors

    Benchmark
    Thrive Capital
    F-Prime Capital
  • Series A

    $7,000,000

    Series A Investors

    Thrive Capital
    Andreessen Horowitz
  • Seed

    $5,000,000

    Seed Investors

    Christopher Golda
    Kevin Mahaffey
    Thrive Capital
    Andreessen Horowitz
    Natalie Carnegie
  • Seed

    $900,000

    Seed Investors

    Y Combinator
    SVA
Funding info provided by Diffbot.